<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01793584</url>
  </required_header>
  <id_info>
    <org_study_id>STU 032012-067</org_study_id>
    <nct_id>NCT01793584</nct_id>
  </id_info>
  <brief_title>Surgical Success After Laparoscopic vs Abdominal Hysterectomy</brief_title>
  <official_title>Randomized Trial of Laparoscopic Versus Abdominal Hysterectomy for Benign Indications and Impact on Surgical Success</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Texas Southwestern Medical Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Texas Southwestern Medical Center</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of the proposed pilot study is to investigate the effectiveness, cost, safety,
      and long-term impact on quality of life of laparoscopic hysterectomy (LH) in relation to
      abdominal hysterectomy (AH) for the treatment of benign gynecologic disease in women through
      a randomized surgical trial.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The overall hypothesis is that neither mode of hysterectomy will be consistently superior to
      the other with respect to each of the three domains of complications, cost, and
      patient-centered outcomes. The overall goal of the study is to determine which clinically
      relevant factors may impact the choice of LH compared to AH. The results of the study may be
      useful for clinicians, patients, hospital administrators and health policy makers.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>February 2013</start_date>
  <completion_date type="Actual">December 31, 2016</completion_date>
  <primary_completion_date type="Actual">December 31, 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Health Services Research</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Quality of life</measure>
    <time_frame>1 year</time_frame>
    <description>1) Patient-centered outcomes composite
Quality of life - measured using the Short Form 12 (SF-12v2),
Sexual functioning - measured using the Sexual Activity Questionnaire (SAQ)
Body image - measured using the Body Image Scale (BIS)
Return to normal activity -measured using the Activities Assessment Scale (AAS)
Pain - measured using a 10 point likert scale
Productivity - measured using a questionnaire about missed work</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Cost</measure>
    <time_frame>1 year</time_frame>
    <description>Hospital charges and indirect costs of missed work/caregiving due to hysterectomy will be calculated</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Complications</measure>
    <time_frame>1 year</time_frame>
    <description>Intraoperative and postoperative complications including conversions, unintentional lacerations/injury to organs, hemorrhage, infection, wound complications, VTE, death, pain, neuropathy</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">100</enrollment>
  <condition>Metrorrhagia</condition>
  <condition>Menorrhagia</condition>
  <condition>Leiomyoma</condition>
  <condition>Adenomyosis</condition>
  <condition>Pelvic Pain</condition>
  <condition>Endometriosis</condition>
  <condition>Pelvic Inflammatory Disease</condition>
  <arm_group>
    <arm_group_label>Laparoscopic hysterectomy</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Total laparoscopic hysterectomy, laparoscopic assisted vaginal hysterectomy</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Abdominal hysterectomy</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Total Abdominal Hysterectomy</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Laparoscopic hysterectomy</intervention_name>
    <description>LAVH, TLH</description>
    <arm_group_label>Laparoscopic hysterectomy</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Abdominal hysterectomy</intervention_name>
    <description>TAH</description>
    <arm_group_label>Abdominal hysterectomy</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Women undergoing hysterectomy for benign indications within 8 weeks of enrollment

          -  Women &gt;18 years of age

          -  Non-emergent surgery

          -  Non-pregnant

        Exclusion Criteria:

          -  Candidate for vaginal hysterectomy

          -  Uterine size &gt;14 weeks by clinical exam OR &gt;300 mL by ultrasound measurement

          -  History of cancer of reproductive tract

          -  Requires concomitant pelvic organ prolapse (POP) surgery

          -  Requires surgery for urinary incontinence

          -  Has acute angle glaucoma

          -  Has severe cardiac/respiratory disease

          -  Desires supracervical hysterectomy
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Kimberly Kho, MD, MPH</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Texas Southwestern Medical Center</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Parkland Hospital</name>
      <address>
        <city>Dallas</city>
        <state>Texas</state>
        <zip>75235</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>October 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 13, 2013</study_first_submitted>
  <study_first_submitted_qc>February 13, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 15, 2013</study_first_posted>
  <last_update_submitted>October 24, 2017</last_update_submitted>
  <last_update_submitted_qc>October 24, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">October 26, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Texas Southwestern Medical Center</investigator_affiliation>
    <investigator_full_name>Kinberly Kho</investigator_full_name>
    <investigator_title>Associate Professor, Department of Obstetrics and Gynecology</investigator_title>
  </responsible_party>
  <keyword>Comparative effectiveness</keyword>
  <keyword>Surgical success</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Endometriosis</mesh_term>
    <mesh_term>Pelvic Pain</mesh_term>
    <mesh_term>Leiomyoma</mesh_term>
    <mesh_term>Menorrhagia</mesh_term>
    <mesh_term>Adenomyosis</mesh_term>
    <mesh_term>Pelvic Inflammatory Disease</mesh_term>
    <mesh_term>Pelvic Infection</mesh_term>
    <mesh_term>Metrorrhagia</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

